Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
ФГБНУ «Научный центр психического здоровья», Москва, Россия klushnik2004@mail.ru
Список исп. литературыСкрыть список 1. Смулевич А.Б. Психосоматические расстройства (психопатология и клиническая систематика). В кн.: Психические расстройства в клинической практике. М.: МЕДпресс-информ, 2011; с. 5–99. / Smulevich A.B. Psikhosomaticheskie rasstroistva (psikhopatologiia i klinicheskaia sistematika). V kn.: Psikhicheskie rasstroistva v klinicheskoi praktike. M.: MEDpress-inform, 2011; s. 5–99. [in Russian] 2. Лебедев К.А., Понякина И.Д. Иммунология образраспознающих рецепторов (интегральная иммунология). М.: Либроком, 2009. / Lebedev K.A., Poniakina I.D. Immunologiia obrazraspoznaiushchikh retseptorov (integral'naia immunologiia). M.: Librokom, 2009. [in Russian] 3. Doyle TA, de Groot M, Harris T et al. Diabetes, depressive symptoms, and inflammation in older adults: results from the Health, Aging, and Body Composition Study. J Psychosom Res 2013; 75 (5): 419–24. 4. Raggi P, Genest J, Giles JT et al. Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions. Atherosclerosis 2018; 276: 98–108. 5. Arend J, Kegler A, Caprara ALF et al. Depressive, inflammatory, and metabolic factors associated with cognitive impairment in patients with epilepsy. Epilepsy Behav 2018; 86: 49–57. 6. Bhatelia K, Singh K, Singh. RTLRs: linking inflammation and breast cancer. Cell Signal 2014; 26 (11): 2350–7. 7. Vidya MK, Kumar VG, Sejian V et al. Toll-like receptors: Significance, ligands, signaling pathways, and functions in mammals. Int Rev Immunol 2018; 37 (1): 20–36. 8. Pozzi D, Menna E, Canzi A et al. The Communication Between the Immune and Nervous Systems: The Role of IL-1β in Synaptopathies. Front Mol Neurosci 2018; 5 (11): 111. 9. Michael R, Irwin MD. Inflammation at the intersection of behavior and somatic symptoms. Psychiatr Clin North Am 2011; 34 (3): 10.1016. 10. Camacho-Arroyo I, Lopez-Griego L, Morales-Montor J. The role of cytokines in regulation of neurotransmission. Neuroimmunomodulation 2009; 16: 1–12. 11. Malynn S, Campos-Torres A, Moynagh P, Haase J. The pro-inflammatory cytokine TNF-α regulates the activity and expression of the serotonin transporter (SERT) in astrocytes. Neurochem Res 2013; 38 (4): 694–704. 12. Шилов Ю.Е., Безруков М.В. Кинурениновый путь распада триптофана. Вестн. РАМН. 2013; 1: 35–41. / Shilov Iu.E., Bezrukov M.V. Kinureninovyi put' raspada triptofana. Vestn. RAMN. 2013; 1: 35–41. [in Russian] 13. Тиганов А.С., Копейко Г.И., Брусов О.С., Клюшник Т.П. Новое в исследовании патогенеза и терапии эндогенной депрессии. Журн. неврологии и психиатрии им. С.С.Корсакова. 2012; 112 (11): 65–72. / Tiganov A.S., Kopeiko G.I., Brusov O.S., Kliushnik T.P. Novoe v issledovanii patogeneza i terapii endogennoi depressii. Zhurn. nevrologii i psikhiatrii im. S.S.Korsakova. 2012; 112 (11): 65–72. [in Russian] 14. Zhang Z. Kynurenine pathway metabolic balance influences microglia activity: Targeting kynurenine monooxygenase to dampen neuroinflamation. Psychoneuroendocrinology 2018; 94: 1–10. 15. Badawy AA. Kynurenine Pathway of Tryptophan Metabolism: Regulatory and Functional Aspects. Int J Tryptophan Res 2017; 10: 17. 16. Barrientos RM, Sprunger DB, Campeau S et al. BDNF – mRNA expression in rat hippocampus following contextual learning is blocked by intrahippocampal IL-1 beta administration. J Neuroimmunol 2004; 155: 119–26). 17. Bluthe RM, MIchaud B, Kelley KW et al. Vagotomy blocks behavioral effects of interleukin-1 injected via the intraperitoneal route but not via other systemic routes. Neuroreport 1996; 7: 2823–7. 18. Navarro VP, Iyomasa MM, Leite-Panissi CR et al. New role of trigeminal nerves as a neuronal pathway signaling brain in acute periodontitis: participation of local prostaglandins. Pflugers Arch 2006; 453: 73–82. 19. Dantzer R. Cytokine-induced sickness behavior: mechanism and implication. Ann N Y Acad Sci 2001; 933: 222–34. 20. Reichhenberg A, Yirmiya R, Schuld A et al. Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psy-chiatry 2001; 58: 445–52. 21. Мaes M. Major Depression and Activation of The Inflammatory Response System. Cytokines, Stress, and Depression. Adv Exp Med Biol 1999; 461: 25–46. 22. Capuron L, Ravaud A, Neveu PJ et al. Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy. Mol Psychiatry 2002; 7: 468–73. 23. Blerhaus A, Wolf J, Andrassy M et al. A mechanism converting psychosocial stress into mononuclear cell activation. Proc Natl Acad Sci USA 2003; 100: 1920–5. 24. Johnson JD, О'Connor КА, Deak Т et al. Prior stressor exposure sensitizes LPS – indused cytokine production. Brain Behav Immun 2002; 16: 461–76. 25. Anisman H, Merali Z, Hayley S. Sensitization associated with stressor and cytokine treatments. Brain Behav Immun 2003; 17: 86–93. 26. Клюшник Т.П., Зозуля С.А., Андросова Л.В. и др. Иммунологический мониторинг эндогенных приступообразных психозов. Журн. неврологии и психиатрии им. С.С.Корсакова. 2014; 2: 37–42. / Kliushnik T.P., Zozulia S.A., Androsova L.V. i dr. Immunologicheskii monitoring endogennykh pristupoobraznykh psikhozov. Zhurn. nevrologii i psikhiatrii im. S.S.Korsakova. 2014; 2: 37–42. [in Russian] 27. Клюшник Т.П., Зозуля С.А., Андросова Л.В. и др. Лабораторная диагностика в мониторинге пациентов с эндогенными психозами («Нейро-иммуно-тест»): Мед. технология. 2-е изд., испр. и доп. М.: Медицинское информационное агентство, 2016. / Kliushnik T.P., Zozulia S.A., Androsova L.V. i dr. Laboratornaia diagnostika v monitoringe patsientov s endogennymi psikhozami ("Neiro-immuno-test'): Med. tekhnologiia. 2-e izd., ispr. i dop. M.: Meditsinskoe informatsionnoe agentstvo, 2016. [in Russian] 28. Волель Б.А., Макух Е.А., Лебедева М.В. и др. Клинико-лабораторные маркеры астенического синдрома у больных саркоидозом. Врач. 2016; 7: 74–6. / Volel' B.A., Makukh E.A., Lebedeva M.V. i dr. Kliniko-laboratornye markery astenicheskogo sindroma u bol'nykh sarkoidozom. Vrach. 2016; 7: 74–6. [in Russian] 29. Голимбет В.Е., Лежейко Т.В., Алфимова М.В. и др. Ген кинуренин-3-монооксигеназы ассоциирован с шизофренией. Генетика. 2014; 50 (6): 724–8. / Golimbet V.E., Lezheiko T.V., Alfimova M.V. i dr. Gen kinurenin-3-monooksigenazy assotsiirovan s shizofreniei. Genetika. 2014; 50 (6): 724–8. [in Russian] 30. Лежейко Т.В., Голимбет В.Е., Андрющенко А.В. и др. Исследование связи гена кинуренин-3-монооксигеназы с депрессией. Журн. неврологии и психиатрии им. С.С.Корсакова. 2016; 116 (12): 92–5. / Lezheiko T.V., Golimbet V.E., Andriushchenko A.V. i dr. Issledovanie sviazi gena kinurenin-3-monooksigenazy s depressiei. Zhurn. nevrologii i psikhiatrii im. S.S.Korsakova. 2016; 116 (12): 92–5. [in Russian] 31. Kim JM, Stewart R, Kim SW et al. Associations of cytokine gene polymorphisms with post-stroke depression. World J Biol Psychiatry 2012; 12 (8): 579–87. 32. Голимбет В.Е., Волель Б.А., Коровайцева Г.И. и др. Связь генов воспалительных факторов с невротизмом, тревожностью и депрессией у мужчин с ишемической болезнью сердца. Журн. неврологии и психиатрии им. С.С.Корсакова. 2017; 117 (3): 74–9. / Golimbet V.E., Volel' B.A., Korovaitseva G.I. i dr. Sviaz' genov vospalitel'nykh faktorov s nevrotizmom, trevozhnost'iu i depressiei u muzhchin s ishemicheskoi bolezn'iu serdtsa. Zhurn. nevrologii i psikhiatrii im. S.S. Korsakova. 2017; 117 (3): 74–9. [in Russian] 33. Якимец А.В., Зозуля С.А., Олейчик И.В., Клюшник Т.П. Oсобенности динамики клинико-биологических показателей астенического симптомокомплекса у больных шизофренией в процессе иммунотропной терапии. Журн. неврологии и психиатрии им. С.С.Корсакова. 2018; 3: 70–6. / Iakimets A.V., Zozulia S.A., Oleichik I.V., Kliushnik T.P. Osobennosti dinamiki kliniko-biologicheskikh pokazatelei astenicheskogo simptomokompleksa u bol'nykh shizofreniei v protsesse immunotropnoi terapii. Zhurn. nevrologii i psikhiatrii im. S.S.Korsakova. 2018; 3: 70–6. [in Russian] 34. Nicklas BJ, Hsu FC, Brinkley TJ et al. Exercise training and plasma C-reactive protein and interleukin-6 in elderly people. J Am Geriar Sos 2008; 56: 2045–52. 35. Madhusudan S, Muthuramalingam SR, Braybrooke JP et al. Study of etanercept, a tumor necrosis factor-alpha ingibitor, in recurrent ovarion cancer. J Clin Oncol 2005; 24: 5950–9. 36. Joel E. Dimsdale and Robert Dantzet. A biological substrat of somatoform disorders: importance of pathopsysiology. Psychosom Med 2007; 69 (9): 850–4. 37. Strik JJ, Honig A, Lousberg R et al. Efficacy and safety of fluoxetine in the treatment of patients with major depression after first myocardial infarction: findings from a double-blind, placebo-controlled trial. Psychosom Med 2000; 62: 783–9. 38. Davidson KW. Assessment and Treatment of Depression in Patients With Cardiovascular Disease: National Heart, Lung, and Blood Institute Working Group Report. Psychosomatic Med 2006; 68: 645–50. 39. Maurer-Spurej E, Pittendreigh C, Solomons K et al. The influence of selective serotonin reuptake inhibitors on human platelet serotonin. Thromb Haemost 2004; 91 (1): 119–28. 40. Clarke H, Flint J, Attwood AS et al. Association of the 5-HTTLPR genotype and unipolar depression: a meta-analysis. Psychol Med 2010; 40 (11): 1767–78. 41. Munafo MR, Clark TG, Moore LR et al. Genetic polymorphisms and personality in healthy adults: a systematic review and meta-analysis. Mol Psychiatry 2003; 8: 471–84. 42. Karg K, Burmeister M, Shedden K et al. The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: evidence of genetic moderation. Arch Gen Psychiatry 2011; 68 (5): 444–54. 43. Ejiri J, Inoue N, Kobayashi S et al. Possible role of brain-derived neurotrophic factor in the pathogenesis of coronary artery disease. Circulation 2005; 112: 2114–20. 44. Duman RS, Heninger GR, Nestler EJ. A molecular and cellular theory of depression. Arch Gen Psychiatry 1997; 54: 597–606. 45. Nakatani D, Sato H, Sakata Y et al. Acute Coronary Insufficiency Study Group: Influence of serotonin transporter gene polymorphism on depressive symptoms and new cardiac events after acute myocardial infarction. Am Heart J 2005; 150: 652–8. 46. Otte C, McCaffery J, Ali S et al. Association of a serotonin transporter polymorphism (5-HTTLPR) with depression, perceived stress, and norepinephrine in patients with coronary disease: the Heart and Soul Study. Am J Psychiatry 2007; 164: 1379–84. 47. Mössner R, Henneberg A, Schmitt A et al. Allelic variation of serotonin transporter expression is associated with depression in Parkinson’s disease. Mol Psychiatry 2001; 6: 350–3. 48. Guo WY, Zhang ZH, Mu JL et al. Relationship between 5-HTTLPR polymorphism and post-stroke depression. Genet Mol Res 2016;15 (1). DOI: 10.4238/gmr.15017460